The Dark Proteome: A New Frontier in Drug Discovery

​The Dark Proteome: A New Frontier in Drug Discovery
Inaugural Greater Boston Gathering

​Roughly 98% of the human genome was long regarded as non-coding, yet it encodes a vast and largely uncharacterized layer of biology: the dark proteome, comprising hundreds of thousands of novel proteins arising from non-canonical open reading frames. This inaugural gathering introduces the field to the Greater Boston research and industry community and brings together three organizations whose capabilities span discovery, data infrastructure, and clinical validation.

​The Collaboration

• ​NonExomics — Discovery, characterization, prioritization, and de-risking of novel targets and therapeutic candidates from the non-canonical genome.

• ​Persistent Systems — Production-grade AI engineering and secure, scalable data infrastructure for the life sciences.

• ​VCR Park — Patient-derived organoid models, advanced imaging, and a clinical network for functional and translational validation.

​Program
9:00 – 9:30 · Breakfast, coffee, and registration
9:30 – 9:50 · Opening remarks: the challenge of novel targets and unexplored biology
9:50 – 10:20 · The dark proteome: an emerging field — Sudhakaran Prabakaran
10:20 – 10:45 · Discovery and characterization of non-canonical proteins — NonExomics
10:45 – 10:55 · Break
10:55 – 11:15 · Computational infrastructure for dark proteome science — Persistent Systems
11:15 – 11:35 · Functional and clinical validation — VCR Park
11:35 – 12:00 · Panel discussion and open floor

​By invitation. Breakfast served.